Rat Aortic Smooth Muscle Cells: RAOSMC, adult
SIGMA/R354-05A
Product Type: Product-on-demand
Rat Aortic Smooth Muscle Cells: RAOSMC
| biological source | rat aorta (healthy adult tunica intima and media) |
| growth mode | Adherent |
| manufacturer/tradename | Cell Applications, Inc |
| morphology | smooth muscle |
| packaging | pkg of 500,000 cells |
| relevant disease(s) | cardiovascular diseases |
| shipped in | dry ice |
| storage temp. | −196°C |
| technique(s) | cell culture | mammalian: suitable |
| Analysis Note: | Each lot was tested for proper morphology, Population Doublings, Negative for HIV, Hepatitis B, Hepatitis C, mycoplasma, bacteria, and fungi. |
| Application: | Aortic wall contraction, role of smc under normal conditions, blood pressure, distribution of oxygenated blood through systemic circulation. |
| Biochem/physiol Actions: | Aorta |
| General description: | Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details. RAOSMC provide an excellent model system to study all aspects of cardiovascular function and disease, especially those related to mechanisms of hyperplasia and hypertrophy of intimal smooth muscle cells leading to vascular occlusion in atherosclerosis and stent restenosis. RAOSMC from Cell Applications, Inc. have been utilized in dozens of research studies to: • Provide a gold standard control for smooth muscle markers Ͱ-SMA, calponin and caldesmon expression (Imamura, 2010) • Elucidate cytokines and growth factors signaling pathways implicated in the molecular regulation of smooth muscle cell proliferation, migration, and overall vascular function (Alexis, 2009; Liu, 2009; Tan, 2009; Ko, 2012; Malabanan, 2012; Santiago, 2012; Newaz, 2013); and demonstrate that peach extract is able to inhibit Ang II-induced intracellular Ca2+ elevation and the generation of ROS, thus showing promise in prevention of cardiovascular diseases (Kono, 2013) • Investigate extracellular matrix properties and its role in cardiovascular health, repair of damaged vasculature and successful tissue engineering (Chiang, 2009; Kothapalli, 2009a,b,c) • Demonstrate that hyperglycemia-induced elastin degradation products lead to vascular smooth muscle cell calcification and identify periostin, also implicated in mechanical stress and inflammation responses, as an early marker for this process (Shanmugam, 2013; Sinha, 2013; Yamashita, 2013) • Develop advanced stent technology, including novel surface materials, and drug delivery systems to prevent restenosis and other occlusive vasculopathies (Taite, 2011; Midwinter, 2012; Li, 2013) Characterization: positive for smooth muscle cell specific alpha-actin expression. |
| Other Notes: | Rat Smooth Muscle Cell Basal Medium that contains 10% FBS and 10% DMSO |
| Preparation Note: | • 2nd passage, >500,000 cells in Rat Smooth Muscle Cell Basal Medium that contains 10% FBS and 10% DMSO • Can be cultured at least 16 doublings |
| Preparation Note: | Please refer to the RAOSMC Culture Protocol  . |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −196°C |
| UNSPSC | 41106514 |